BACKGROUND: Defects of cytoarchitectural proteins can cause left ventricular noncompaction, which is often associated with conduction system diseases. We have previously identified a p.D117N mutation in the LIM domain-binding protein 3-encoding Z-band alternatively spliced PDZ motif gene (ZASP) in a patient with left ventricular noncompaction and conduction disturbances. We sought to investigate the role of p.D117N mutation in the LBD3 NM_001080114.1 isoform (ZASP1-D117N) for the regulation of cardiac sodium channel (Na(v)1.5) that plays an important role in the cardiac conduction system. METHODS AND RESULTS: Effects of ZASP1-wild-type and ZASP1-D117N on Na(v)1.5 were studied in human embryonic kidney-293 cells and neonatal rat cardiomyocytes. Patch-clamp study demonstrated that ZASP1-D117N significantly attenuated I(Na) by 27% in human embryonic kidney-293 cells and by 32% in neonatal rat cardiomyocytes. In addition, ZASP1-D117N rightward shifted the voltage-dependent activation and inactivation in both systems. In silico simulation using Luo-Rudy phase 1 model demonstrated that altered Na(v)1.5 function can reduce cardiac conduction velocity by 28% compared with control. Pull-down assays showed that both wild-type and ZASP1-D117N can complex with Na(v)1.5 and telethonin/T-Cap, which required intact PDZ domains. Immunohistochemical staining in neonatal rat cardiomyocytes demonstrates that ZASP1-D117N did not significantly disturb the Z-line structure. Disruption of cytoskeletal networks with 5-iodonaphthalene-1-sulfonyl homopiperazine and cytochalasin D abolished the effects of ZASP1-D117N on Na(v)1.5. CONCLUSIONS: ZASP1 can form protein complex with telethonin/T-Cap and Na(v)1.5. The left ventricular noncompaction-specific ZASP1 mutation can cause loss of function of Na(v)1.5, without significant alteration of the cytoskeletal protein complex. Our study suggests that electric remodeling can occur in left ventricular noncompaction subject because of a direct effect of mutant ZASP on Na(v)1.5.
BACKGROUND: Defects of cytoarchitectural proteins can cause left ventricular noncompaction, which is often associated with conduction system diseases. We have previously identified a p.D117N mutation in the LIM domain-binding protein 3-encoding Z-band alternatively spliced PDZ motif gene (ZASP) in a patient with left ventricular noncompaction and conduction disturbances. We sought to investigate the role of p.D117N mutation in the LBD3 NM_001080114.1 isoform (ZASP1-D117N) for the regulation of cardiac sodium channel (Na(v)1.5) that plays an important role in the cardiac conduction system. METHODS AND RESULTS: Effects of ZASP1-wild-type and ZASP1-D117N on Na(v)1.5 were studied in human embryonic kidney-293 cells and neonatal rat cardiomyocytes. Patch-clamp study demonstrated that ZASP1-D117N significantly attenuated I(Na) by 27% in human embryonic kidney-293 cells and by 32% in neonatal rat cardiomyocytes. In addition, ZASP1-D117N rightward shifted the voltage-dependent activation and inactivation in both systems. In silico simulation using Luo-Rudy phase 1 model demonstrated that altered Na(v)1.5 function can reduce cardiac conduction velocity by 28% compared with control. Pull-down assays showed that both wild-type and ZASP1-D117N can complex with Na(v)1.5 and telethonin/T-Cap, which required intact PDZ domains. Immunohistochemical staining in neonatal rat cardiomyocytes demonstrates that ZASP1-D117N did not significantly disturb the Z-line structure. Disruption of cytoskeletal networks with 5-iodonaphthalene-1-sulfonyl homopiperazine and cytochalasin D abolished the effects of ZASP1-D117N on Na(v)1.5. CONCLUSIONS: ZASP1 can form protein complex with telethonin/T-Cap and Na(v)1.5. The left ventricular noncompaction-specific ZASP1 mutation can cause loss of function of Na(v)1.5, without significant alteration of the cytoskeletal protein complex. Our study suggests that electric remodeling can occur in left ventricular noncompaction subject because of a direct effect of mutant ZASP on Na(v)1.5.
Authors: H L Tan; M T Bink-Boelkens; C R Bezzina; P C Viswanathan; G C Beaufort-Krol; P J van Tintelen; M P van den Berg; A A Wilde; J R Balser Journal: Nature Date: 2001-02-22 Impact factor: 49.962
Authors: Séverine Petitprez; Anne-Flore Zmoos; Jakob Ogrodnik; Elise Balse; Nour Raad; Said El-Haou; Maxime Albesa; Philip Bittihn; Stefan Luther; Stephan E Lehnart; Stéphane N Hatem; Alain Coulombe; Hugues Abriel Journal: Circ Res Date: 2010-12-16 Impact factor: 17.367
Authors: Kazuo Ueda; Carmen Valdivia; Argelia Medeiros-Domingo; David J Tester; Matteo Vatta; Gianrico Farrugia; Michael J Ackerman; Jonathan C Makielski Journal: Proc Natl Acad Sci U S A Date: 2008-06-30 Impact factor: 11.205
Authors: Amelia Mazzone; Peter R Strege; David J Tester; Cheryl E Bernard; Georgine Faulkner; Roberto De Giorgio; Jonathan C Makielski; Vincenzo Stanghellini; Simon J Gibbons; Michael J Ackerman; Gianrico Farrugia Journal: J Biol Chem Date: 2008-04-11 Impact factor: 5.157
Authors: Q Zhou; P H Chu; C Huang; C F Cheng; M E Martone; G Knoll; G D Shelton; S Evans; J Chen Journal: J Cell Biol Date: 2001-11-05 Impact factor: 10.539
Authors: Graham S Adsit; Ravi Vaidyanathan; Carla M Galler; John W Kyle; Jonathan C Makielski Journal: J Mol Cell Cardiol Date: 2013-04-01 Impact factor: 5.000
Authors: Perry Wengrofsky; Christopher Armenia; Filip Oleszak; Eric Kupferstein; Chandra Rednam; Cristina A Mitre; Samy I McFarlane Journal: EC Clin Exp Anat Date: 2019-07-29
Authors: Valentina C Martinelli; W Buck Kyle; Snezana Kojic; Nicola Vitulo; Zhaohui Li; Anna Belgrano; Paolo Maiuri; Lawrence Banks; Matteo Vatta; Giorgio Valle; Georgine Faulkner Journal: PLoS One Date: 2014-03-19 Impact factor: 3.240
Authors: Young Soo Lee; Michael A Olaopa; Byung Chun Jung; Sang Hee Lee; Dong Gu Shin; Hyoung Seob Park; Yongkeun Cho; Sang Mi Han; Myung Hoon Lee; Yoon Nyun Kim Journal: Korean Circ J Date: 2016-01-14 Impact factor: 3.243